Anthony Matthew Battram

8PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Gene and molecular therapyInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited.

Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol

|Dec 06, 2024
Genetic disruption of Blimp-1 drastically augments the antitumor efficacy of BCMA-targeting CAR T cells.

Anthony M Battram, Joan Mañé-Pujol, David F Moreno

|Jul 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma.

Ester Lozano, Mari-Pau Mena, Glòria Garrabou

|Mar 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.

Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta

|Aug 26, 2021
NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness.

Mireia Bachiller, Lorena Perez-Amill, Anthony Matthew Battram

|Jul 24, 2021
IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation.

Anthony M Battram, Mireia Bachiller, Victor Lopez

Pageof 2

Frequent Collaborators

6 joint publications

Beatriz Martín-Antonio

5 joint publications

Carlos Fernández de Larrea

4 joint publications

David F Moreno

4 joint publications

Aina Oliver-Caldés